vs
Side-by-side financial comparison of MEDIFAST INC (MED) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $55.4M, roughly 1.4× PLAYSTUDIOS, Inc.). On growth, PLAYSTUDIOS, Inc. posted the faster year-over-year revenue change (-18.3% vs -36.9%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $-6.6M). Over the past eight quarters, PLAYSTUDIOS, Inc.'s revenue compounded faster (-15.6% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
MED vs MYPS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $55.4M |
| Net Profit | — | $-13.7M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | -17.7% |
| Net Margin | — | -24.7% |
| Revenue YoY | -36.9% | -18.3% |
| Net Profit YoY | — | 38.9% |
| EPS (diluted) | $-1.64 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $55.4M | ||
| Q3 25 | $89.4M | $57.6M | ||
| Q2 25 | $105.6M | $59.3M | ||
| Q1 25 | $115.7M | $62.7M | ||
| Q4 24 | $119.0M | $67.8M | ||
| Q3 24 | $140.2M | $71.2M | ||
| Q2 24 | $168.6M | $72.6M | ||
| Q1 24 | $174.7M | $77.8M |
| Q4 25 | — | $-13.7M | ||
| Q3 25 | $-2.3M | $-9.1M | ||
| Q2 25 | $2.5M | $-2.9M | ||
| Q1 25 | $-772.0K | $-2.9M | ||
| Q4 24 | — | $-22.4M | ||
| Q3 24 | $1.1M | $-3.1M | ||
| Q2 24 | $-8.2M | $-2.6M | ||
| Q1 24 | $8.3M | $-567.0K |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | -17.7% | ||
| Q3 25 | -4.6% | -13.6% | ||
| Q2 25 | -1.0% | -5.9% | ||
| Q1 25 | -1.1% | -4.4% | ||
| Q4 24 | 0.6% | -33.1% | ||
| Q3 24 | 1.5% | -6.7% | ||
| Q2 24 | -4.7% | -5.5% | ||
| Q1 24 | 4.5% | -2.2% |
| Q4 25 | — | -24.7% | ||
| Q3 25 | -2.5% | -15.8% | ||
| Q2 25 | 2.3% | -5.0% | ||
| Q1 25 | -0.7% | -4.6% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | 0.8% | -4.3% | ||
| Q2 24 | -4.8% | -3.6% | ||
| Q1 24 | 4.8% | -0.7% |
| Q4 25 | $-1.64 | $-0.12 | ||
| Q3 25 | $-0.21 | $-0.07 | ||
| Q2 25 | $0.22 | $-0.02 | ||
| Q1 25 | $-0.07 | $-0.02 | ||
| Q4 24 | $0.08 | $-0.18 | ||
| Q3 24 | $0.10 | $-0.02 | ||
| Q2 24 | $-0.75 | $-0.02 | ||
| Q1 24 | $0.76 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $227.9M |
| Total Assets | $248.0M | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $104.9M | ||
| Q3 25 | $173.5M | $106.3M | ||
| Q2 25 | $162.7M | $112.9M | ||
| Q1 25 | $164.6M | $107.1M | ||
| Q4 24 | $162.3M | $109.2M | ||
| Q3 24 | $170.0M | $105.2M | ||
| Q2 24 | $163.5M | $106.3M | ||
| Q1 24 | $156.4M | $127.0M |
| Q4 25 | $198.9M | $227.9M | ||
| Q3 25 | $214.7M | $238.9M | ||
| Q2 25 | $216.0M | $245.3M | ||
| Q1 25 | $211.0M | $244.1M | ||
| Q4 24 | $210.1M | $244.7M | ||
| Q3 24 | $207.3M | $265.2M | ||
| Q2 24 | $205.3M | $263.6M | ||
| Q1 24 | $211.0M | $288.4M |
| Q4 25 | $248.0M | $290.6M | ||
| Q3 25 | $268.2M | $299.2M | ||
| Q2 25 | $269.3M | $316.2M | ||
| Q1 25 | $280.0M | $313.8M | ||
| Q4 24 | $284.2M | $323.0M | ||
| Q3 24 | $291.2M | $330.6M | ||
| Q2 24 | $293.5M | $333.4M | ||
| Q1 24 | $302.8M | $357.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $3.7M |
| Free Cash FlowOCF − Capex | $-6.6M | $3.6M |
| FCF MarginFCF / Revenue | -8.8% | 6.5% |
| Capex IntensityCapex / Revenue | 1.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $3.7M | ||
| Q3 25 | $12.1M | $5.7M | ||
| Q2 25 | $-3.4M | $13.6M | ||
| Q1 25 | $3.4M | $3.3M | ||
| Q4 24 | $-4.9M | $11.6M | ||
| Q3 24 | $9.1M | $14.6M | ||
| Q2 24 | $13.1M | $14.5M | ||
| Q1 24 | $7.3M | $5.0M |
| Q4 25 | $-6.6M | $3.6M | ||
| Q3 25 | $10.8M | $5.4M | ||
| Q2 25 | $-4.8M | $13.2M | ||
| Q1 25 | $1.9M | $3.2M | ||
| Q4 24 | $-7.2M | $11.5M | ||
| Q3 24 | $7.7M | $13.9M | ||
| Q2 24 | $11.1M | $12.8M | ||
| Q1 24 | $5.4M | $3.6M |
| Q4 25 | -8.8% | 6.5% | ||
| Q3 25 | 12.0% | 9.3% | ||
| Q2 25 | -4.5% | 22.3% | ||
| Q1 25 | 1.6% | 5.1% | ||
| Q4 24 | -6.1% | 16.9% | ||
| Q3 24 | 5.5% | 19.6% | ||
| Q2 24 | 6.6% | 17.6% | ||
| Q1 24 | 3.1% | 4.6% |
| Q4 25 | 1.8% | 0.2% | ||
| Q3 25 | 1.5% | 0.5% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.0% | 0.9% | ||
| Q2 24 | 1.1% | 2.4% | ||
| Q1 24 | 1.1% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
